This has led to the hope that similar products may be developed for hMPV, and Moderna has recently started trials into a mRNA hMPV vaccine. There are no treatments that have been clearly ...

Last summer, scientists at the University of Oxford launched a clinical trial of a combined RSV and hMPV vaccine in partnership with Moderna, and Andrew Pollard, a professor of infection and ...

Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

News reports and social media posts are warning of a new outbreak of a little-known virus called human metapneumovirus (HMPV) in China, but officials are yet to confirm this. Instead, official ...

Most children have had HMPV by the time they reach the age of ... There’s currently no cure or vaccine for the disease, though Moderna, the maker of a COVID-19 vaccine, is working to produce ...

Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...

Authorities in China said they are monitoring cases of human metapneumovirus, or HMPV, after a reported increase inside the country, according to Reuters. Although cases are increasing at a rapid ...

Cases of human metapneumovirus (HMPV) have also been reported from India amid seasonal winter patterns of a rise in respiratory illnesses. The surge of the cases in early December has raised ...

HMPV commonly circulates during respiratory virus season, experts say. Chinese health officials are reportedly monitoring an increase in cases of human metapneumovirus (HMPV). There is currently ...

Analysis - Five years on from the first news of Covid-19, recent reports of an obscure respiratory virus in China may ...